Literature DB >> 21145280

The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency.

Sebastiaan Overeem1, Sofie J van Nues, Wendy L van der Zande, Claire E Donjacour, Petra van Mierlo, Gert Jan Lammers.   

Abstract

BACKGROUND: Narcolepsy is often not recognized or accurately diagnosed. This may be due to the fact that cataplexy, a core symptom which is virtually 100% specific, can-in practice-only be diagnosed based on the patient's history. However, the current definition of cataplexy is not very precise and the common distinction between "typical" and "atypical" cataplexy is not well codified.
METHODS: We aimed to provide a detailed description of the phenotypic variability of cataplexy. We included 109 patients with a definite history of cataplexy and a proven hypocretin-1 deficiency. The questionnaire contained 37 items to broadly cover the clinical aspects of cataplexy, including triggers, pattern and duration of muscle weakness, associated aspects such as sensory phenomena, and limitations in daily life due to cataplexy.
RESULTS: "Laughing" only listed in place 11th of most frequent triggers. "Laughing excitedly" was much more potent, showing that a certain intensity of the emotion is important for a "cataplectogenic" effect. Anger was the highest ranking "non-humorous" trigger, followed by "unexpectedly meeting someone well known." About 60% of patients also had spontaneous cataplectic attacks. Forty-five percent of patients experienced both partial and complete attacks and 30% only partial cataplexy. Fifteen percent of complete attacks were reported to last longer than 2 min. An abrupt return of muscle function was an important feature. The jaw and the face were most often involved in partial attacks, even more than the knee or the leg.
CONCLUSIONS: Cataplexy presents with a large phenotypical diversity, so the current "typical" versus "atypical" distinction may be difficult to hold. We propose that grading cataplexy with different levels of diagnostic confidence may be more useful.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145280     DOI: 10.1016/j.sleep.2010.05.010

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  31 in total

1.  Sleep dynamics beyond traditional sleep macrostructure.

Authors:  Giuseppe Plazzi; Fabio Pizza
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

2.  Narcolepsy Type 1 and Idiopathic Generalized Epilepsy: Diagnostic and Therapeutic Challenges in Dual Cases.

Authors:  Simone Baiardi; Stefano Vandi; Fabio Pizza; Lara Alvisi; Lucia Toscani; Elena Zambrelli; Paolo Tinuper; Geert Mayer; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

3.  GABAergic Neurons of the Central Amygdala Promote Cataplexy.

Authors:  Carrie E Mahoney; Lindsay J Agostinelli; Jessica N K Brooks; Bradford B Lowell; Thomas E Scammell
Journal:  J Neurosci       Date:  2017-02-24       Impact factor: 6.167

4.  Narcolepsy in the pediatric population.

Authors:  Erick N Viorritto; Suraiya A Kureshi; Judith A Owens
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

5.  Giving a voice to cataplectic experience: recollections from patients with narcolepsy type 1.

Authors:  Christian Franceschini; Chiara Fante; Maria Claudia Folli; Maria Filosa; Fabio Pizza; Elena Antelmi; Francesca Ingravallo; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

6.  Narcolepsy with Cataplexy in an Elderly Woman.

Authors:  Shingo Suzuki; Takanori Uehara; Yoshiyuki Ohira; Masatomi Ikusaka
Journal:  J Gen Intern Med       Date:  2015-03-18       Impact factor: 5.128

Review 7.  Cataplexy and Its Mimics: Clinical Recognition and Management.

Authors:  Sigrid Pillen; Fabio Pizza; Karlien Dhondt; Thomas E Scammell; Sebastiaan Overeem
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

Review 8.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

Review 9.  Patient-Reported Measures of Narcolepsy: The Need for Better Assessment.

Authors:  Ulf Kallweit; Markus Schmidt; Claudio L Bassetti
Journal:  J Clin Sleep Med       Date:  2017-05-15       Impact factor: 4.062

Review 10.  The anatomical, cellular and synaptic basis of motor atonia during rapid eye movement sleep.

Authors:  Elda Arrigoni; Michael C Chen; Patrick M Fuller
Journal:  J Physiol       Date:  2016-07-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.